ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,715, issued on April 15, was assigned to Raydel Korea Co. Ltd. (Seoul, South Korea).
"Method for maximizing coronavirus killing activity of high-density lipoproteins, and pharmaceutical composition for preventing or treating COVID-19" was invented by Kyung-Hyun Cho (Daegu, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates a method for maximizing the coronavirus killing activity of high-density lipoproteins, and a pharmaceutical composition for preventing or treating COVID-19. As identified by the present inventors, non-glycated normal high-density lipoproteins (HDLs) exhibit killing activity against coronavirus ...